
Founded
2010
16 years
Employees
51-200
Annual Revenue
Not Disclosed
(2026)
Products
1
ZenQMS LLC is a Pennsylvania-based, privately-held electronic quality management system (eQMS) vendor founded in 2010 by Panos Boudouvas (Co-Founder & CEO) and Graham Wert (Co-Founder & CTO), both of whom remain in role. Headquartered in Ardmore, Pennsylvania (suburban Philadelphia), the company describes itself as a life-sciences-specialized platform — "purpose-built for Life Sciences companies" — covering biopharmaceutical, CDMO/CMO, CRO, medical device, laboratory, packaging, and logistics verticals. The company operates from an estimated ~80–96 employees with team presence across North America, South America, and Europe. ZenQMS states it serves "hundreds of life sciences companies around the world" with 44 published customer case studies.
The company was self-funded from inception until October 2022, when Susquehanna Growth Equity (SGE) took a minority growth-equity stake — the only institutional round on record. SGE publicly characterized ZenQMS at the time of investment as "profitable, growing" and noted that ZenQMS was not seeking capital. The platform is cloud-hosted exclusively on AWS with a multi-tenant architecture and no on-premise option. The vendor's pricing model includes all modules at a flat annual fee with unlimited users.
ZenQMS is a life-sciences-specialized eQMS. The vendor describes the product as "purpose-built for Life Sciences companies" and validated for FDA 21 CFR Part 11, EU Annex 11, and relevant GxP/ISO requirements. Verticals explicitly targeted include biopharmaceutical, CDMO/CMO, CRO, medical device, laboratory, packaging, and logistics organizations.
Named, publicly disclosed customers span emerging-to-mid biotech and contract service organizations: Agenus Inc. (immuno-oncology), Bimeda (animal health/pharma, 80+ countries), TriRx Pharmaceutical Services (CDMO, 11+ sites), BioAgilytix (CRO, multiple continents), Solid Biosciences (expanded from acquired AavantiBio instance), Omega Therapeutics, Uniquity Bio, Vanqua Bio, Axolotl Biologix, Avara Pharmaceutical Services, Xpress Biologics (Belgium), Advarra, Biorasi, Marken (supply chain, 30 countries), and Clarivate (information services). The vendor publishes 44 customer case studies in total. Customer concentration is in emerging-to-mid biotech, CDMOs, and CROs. No top-20 Big Pharma is publicly named as a ZenQMS customer. The Bimeda case study notes FDA and HPRA (Ireland) off-site inspections conducted using ZenQMS records. Net revenue retention and pharma-only segmentation are not publicly disclosed.
Industries Served
ZenQMS is a privately held LLC and does not publicly disclose annual revenue, ARR, growth rate, or profitability metrics. The only institutional funding event on record is a minority growth-equity investment by Susquehanna Growth Equity (SGE), announced October 4, 2022. Financial terms were undisclosed. SGE publicly characterized ZenQMS at investment time as "profitable, growing" and noted the company "wasn't looking for cash." Prior to this round, the company was self-funded from its 2010 founding, approximately 12 years of bootstrapped operation.
Third-party aggregator LeadIQ estimates annual revenue at $25–50 million; this is a model-derived estimate, not a vendor-disclosed figure. No subsequent funding rounds have been reported. Post-money valuation is undisclosed. ZenQMS has made no acquisitions, and no public sale-process signals exist.
Browse all software products offered by ZenQMS.
ZenQMS sells a single integrated eQMS platform. All core modules are included in the base annual fee with unlimited users. Core modules as listed on the product overview page include: Documents (controlled document lifecycle, version control, eSignature), Training (SOP review tracking, role-based assignments, on-the-job training), Issues (CAPAs, deviations, non-conformances with configurable closed-loop workflows), Change Control, Audits (internal/external audit planning, supplier qualification), and Quality Insights (analytics/reporting layer). The platform is deployed as a single, validated, multi-tenant cloud instance on AWS with an uptime target of >99.99%. No on-premise option exists. Customers access via browser only. Release cadence is 2–4 major upgrades per year, each shipped with validation documentation, IQ/OQ/PQ artifacts, and a test environment.
Add-on and newer product offerings include: **ZenSign**, embedded Part-11-compliant eSignature enabling external-party signatures (vendors, contractors) without leaving the validated platform; **QATalyst**, a pre-configured implementation package providing SOP templates, pre-built training structures, roles, and out-of-the-box workflows for early-stage customers; and **AI-Powered Quality**, a top-level product category on the vendor's site. Recent AI launches include **AI Smart Search**, generally available, which applies natural-language query across document attributes, and **AI-assisted training question generation**, which the vendor describes as coming "soon" — roadmap status, not yet shipped. AI features are opt-in and human-in-the-loop. Customer data is not used to train third-party LLMs, and validation materials are provided. In March 2026 ZenQMS launched integration with Blue Mountain RAM® (EAM/calibration), the first listing in ZenQMS's nascent integration marketplace.
ZenQMS's cloud infrastructure is exclusively hosted on Amazon Web Services (AWS). The vendor names AWS as the sole hosting partner and states there is no alternative-region hosting option. AWS infrastructure carries SSAE 16 SOC 1/2/3 and ISO 27001 certifications independently.
Named consulting and technology partners include USDM Life Sciences, Blue Mountain RAM®, and BioPharma Institute. USDM Life Sciences (formal partnership announced March 2023) provides Cloud Assurance Certification with an automated testing tool (ATT) that replaces manual OQ for ZenQMS customer validations, an annual vendor audit, accelerated validation, and ongoing regression testing. Blue Mountain RAM® is a strategic partnership with bi-directional EAM/calibration/maintenance/validation integration, announced March 24, 2026, and positioned as the first listing in the ZenQMS integration marketplace. BioPharma Institute provides regulatory/validation/GxP training content. Pre-configured portfolio-rollout services are evidenced in the PBM Capital case study, where a base QMS Foundation is cloned across portfolio biotechs.
No Tier-1 SI partnerships (Deloitte, Accenture, PwC, EY, etc.) or pharma-niche SI partnerships (ProPharma, Halloran, Cognizant, etc.) are publicly disclosed. ZenQMS is not listed on AWS Marketplace, Azure Marketplace, Salesforce AppExchange, or ServiceNow Store. Pre-built connectors to LIMS, ERP, or MES are not yet GA; SharePoint pre-built integration is on the publicly announced roadmap.
Cloud Partners
Technology Partners
ZenQMS provides implementation, validation documentation, and ongoing support in-house, included in the annual fee with no hourly charges and no separate support tiers. The vendor describes support as "personal, helpful, and free" with response time "measured in minutes." Support resources include a knowledge base, helpdesk, and personalized implementation with a validation checklist. Implementation artifacts provided include User Requirements Specification (URS), Functional Requirements Specification (FRS), validation plan, IQ/OQ/PQ protocols, trace matrix, UAT templates, and annual revalidation packages, all included rather than billed as separate professional-services add-ons. Typical implementation timeline stated by the vendor is 90 days or less.
The vendor runs a **Quality Leaders Forum** event series (2026 edition confirmed in South San Francisco), providing an in-person community forum for customers. VP of Customer Success Emily Ruth oversees the customer success function. ZenQMS does not disclose 24/7 support coverage, follow-the-sun coverage, or multi-language support. No formal user certification or credentialing program is published. The USDM Life Sciences partnership also provides customers with Cloud Assurance Certification vendor audit access and automated regression testing as a service-level enhancement.
ZenQMS holds ISO 9001:2015 and ISO 27001:2022 certifications, with certificates viewable on the vendor's trust-and-compliance page. The company also attains SOC 2 Type II (report available to clients via auditor share account, not public download) and USDM Cloud Assurance Certification (downloadable behind a form on usdm.com). The vendor explicitly states it is not directly certified by FDA or any regulatory agency. AWS infrastructure carries SSAE 16 SOC 1/2/3 and ISO 27001 independently. The platform is validated per GAMP 5 Category 4. Supported regulatory frameworks per vendor statements include FDA 21 CFR Part 11, EU Annex 11, GxP, ISO 9001, ISO 27001, HIPAA, and GDPR.
Leadership includes Co-Founder & CEO Panos Boudouvas, Co-Founder & CTO Graham Wert, Chief Software Architect Alin Cobarzan, VP of Customer Success Emily Ruth, VP Quality Assurance Karin Ashkenazi, and VP of Operations Brendan Lawrence. Board member Brian Kelly is listed on Crunchbase. Susquehanna Growth Equity board representation is expected per investment terms, but a specific named seat is not publicly confirmed. The company received a CIOReview "Top 20 QMS Solution Company" designation in 2018. G2 shows a 4.7/5 rating across approximately 100 reviews per vendor citation; Capterra reviews are described as skewing positive. ZenQMS holds no placements in major analyst evaluations (Gartner Magic Quadrant, Forrester Wave, IDC MarketScape, KLAS, Verdantix). The vendor publishes a regularly updated blog, a 2025 market-research report ("Quality Management in Life Sciences: Benchmarks, Burdens, and Breakthroughs"), webinar content, and practical guides for quality teams.
ZenQMS maintains an actively updated website with current product, blog, and resources sections refreshed in 2025–2026. Blog cadence is regular, with multiple posts per month. The vendor publishes a 2025 annual market-research report, webinars, and case studies targeting quality professionals in life sciences. Press release frequency is limited. The most visible 2025–2026 announcements are the Blue Mountain integration (March 24, 2026) and the AI features launch. Prior notable releases include the SGE investment (October 2022), the USDM partnership (March 2023), and a HIPAA compliance announcement (April 2021). The vendor is active on LinkedIn; follower count is undisclosed.
Conference presence includes SCOPE Summit and the vendor's own Quality Leaders Forum series. Core narrative positioning repeated across homepage, product overview, FAQ, and case studies centers on three themes: all-modules-included, unlimited-user pricing with no seat licenses; ease of use for non-administrator users; and validation simplicity, including free validation documents, UAT templates, and USDM-assisted vendor qualification. The vendor publishes 44 customer case studies via casestudies.com and its own testimonials page. No free trial is prominently advertised; the vendor leads with demo requests.
Headquarters
Ardmore, Pennsylvania, United States
Founded
2010 (16 years in business)
Company Size
51-200 employees
Type
Private
Owned by unknown
Annual Revenue
Not Disclosed (2026)
Office Locations